News
The city of Rockford dedicated a memorial plaque to one of their own, who died in November to a form of muscular dystrophy.
Echocardiography may be at the vanguard for early and rapid detection of heart issues indicative of Duchenne muscular ...
Sarepta Therapeutics has provided additional safety data on its gene therapy Elevidys as a Duchenne muscular dystrophy ...
After deaths and FDA setbacks, Sarepta abandoned LGMD gene therapy, leaving families desperate and patients without ...
Certain Sarepta Therapeutics Inc. insiders were accused in a stockholder lawsuit of reaping a combined $6.2 million selling ...
Discover the challenges and opportunities for Keros Therapeutics, Inc., including FDA designations, partnerships, and ...
2d
Stocktwits on MSNCiti Believes FDA May Closely Watch Sarepta’s Safeguards For Gene Therapy In Non-Ambulatory DMD Patients
Citi said on Wednesday that the U.S. Food and Drug Administration may take a “more comprehensive look” at the level of ...
Hosted on MSN21d
Bone Health in Duchenne Muscular Dystrophy
Managing osteoporosis and bone health in Duchenne muscular dystrophy occurs in a high-risk environment for fractures due to disease-related loss of muscle and movement, adverse effects of ...
For adults with Duchenne muscular dystrophy, swallowing-related impairments are associated with age, inspiratory muscle strength, and autonomic dysfunction, say the results of a new study. CMR ...
Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), is pleased to announce the expansion of its leadership team with the ...
Sarcomatrix Therapeutics, a biopharmaceutical company developing small‑molecule treatments for Duchenne muscular dystrophy (DMD), today announced it has received a $300,000 investment from Nevada’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results